HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Allworth Financial LP 1,119$40,3630.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 476$17,1690.00%
Walleye Capital LLC 3,806$137,2820.00%
FMR LLC 129,656$4,676,6840.00%
BROWN BROTHERS HARRIMAN & CO 381$13,7430.00%
US BANCORP \DE\ 8,487$306,1260.00%
Baker Avenue Asset Management, LP 7$2520.00%
PNC FINANCIAL SERVICES GROUP, INC. 12,647$456,1770.00%
CWM, LLC 1,110$400.00%
M&R CAPITAL MANAGEMENT INC 32$1,1540.00%
Twin Tree Management, LP 1,639$59,1190.00%
SJS Investment Consulting Inc. 20$7220.00%
FIRST TRUST ADVISORS LP 5,612$202,4240.00%
Steward Partners Investment Advisory, LLC 300$10,8210.00%
BESSEMER GROUP INC 807$290.00%
Parallel Advisors, LLC 272$9,8110.00%
JFS WEALTH ADVISORS, LLC 42$1,5150.00%
TRUST CO OF VERMONT 200$7,2140.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CENTRAL TRUST Co 300$10,8210.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.